Senior Helpers, one of the largest home senior care companies in the United States, recently announced it has been named the exclusive sponsor of online resources for caregiving for the Michael J. Fox Foundation for Parkinson’s Research. The Michael J. Fox Foundation is a nonprofit organization and a leading funder of Parkinson’s disease research throughout the world, committed to providing educational resources to help organizations and families improve care for those with Parkinson’s disease. Senior Helpers hires and trains caregivers from all over the country to offer care to Parkinson’s patients.
“Sponsoring The Michael J. Fox Foundation is a perfect fit for what we do. One of our most important causes is to train caregivers so they can help seniors remain in their homes even though they are living with conditions such as Parkinson’s disease. Helping The Michael J. Fox Foundation enhance resources that provide guidance for caregivers is right in line with our priorities,” noted Chris Buitron, the Vice President of Marketing for Senior Helpers.
In addition, the Michael J. Fox Foundation will utilize the sponsorship to emphasize its existing caregiver resources and content on its blog and social media channels. The resources are designed to assist families and organizations to better understand how Parkinson’s disease affects relationships and whole families and provides content to help patients understand what life-style might be the best for them. A “Caregiver Guide” is also included in these resources.
People can learn more about Senior Helpers and Parkinson’s disease on the michaeljfox.org website in the “Understanding Parkinson’s” section.
In addition, the Michael J. Fox Foundation for Parkinson’s Research has announced that it is collaborating with The Edmond J. Safra Foundation to select four academic centers across the United States and one more in Canada to host the inaugural class of the Edmond J. Safra Fellowship in Movement Disorders. This program aims to increase resources for clinician-researcher neurologists to receive specialized training in order to grow the global base of specialists available to treat people with Parkinson’s and make substantial contributions to emerging, new research for breakthrough treatments.